Cognitive changes following non-neurologic and non-cardiac surgery were not associated with changes in Alzheimer’s disease-related biomarkers in older patients, according to a study led by a team at Duke University School of Medicine.

A booster dose of Moderna’s COVID-19 vaccine showed signs of waning antibody levels against the Omicron variant after six months, but the antibodies still remained effective against the variant in laboratory tests, according to a Jan. 26 study in the New England Journal of Medicine.

COVID-19 may soon evolve from a chaotic and unpredictable pandemic to a more manageable endemic, but will remain dangerous and require people to remain vigilant, safe and responsible.

Computer engineers and radiologists at Duke University have developed an artificial intelligence platform to analyze potentially cancerous lesions in mammography scans to determine if a patient should receive an invasive biopsy, and it shows physicians exactly how it came to its conclusions.

A new infusion being offered by Duke HomeCare & Hospice. Certain patients who test positive for COVID-19 are eligible for an infusion designed to decrease the risk of transmission, stimulate a stronger immune response, decrease symptoms and make it less likely a recovery in the hospital will be necessary.

Fatima Syed, MD, assistant professor of medicine (General Internal Medicine), has been selected as the new Director of the Primary Care Leadership Track (PCLT) program in the School of Medicine. Syed has served as Associate Director since 2020.

Janice Massey, MD, Professor of Neurology and Senior Vice Chair of the Department of Neurology has been awarded the Lifetime Achievement Award by The American Association of Neuromuscular & Electrodiagnostic Medicine, (AANEM) in recognition of her decades of service to patient care and the field of neurology.

Provost Kornbluth and Dean Klotman discuss the biology of omicron and how Duke is adapting its policies.

Duke researchers have identified a genomic signature which makes it possible to develop a test to identify which men should undergo treatment early in their diagnosis, vs. those who could safely postpone therapy, if they need it at all.

Your taste buds may or may not be able to tell real sugar from a sugar substitute like Splenda, but there are cells in your intestines that can and do distinguish between the two sweet solutions. And they can communicate the difference to your brain in milliseconds.